Cargando…
Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke
BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is whether hospitals accurately perceive their rate of tPA “door-to-needle” (DTN) t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608060/ https://www.ncbi.nlm.nih.gov/pubmed/26201547 http://dx.doi.org/10.1161/JAHA.114.001298 |
_version_ | 1782395599072526336 |
---|---|
author | Lin, Cheryl B Cox, Margueritte Olson, DaiWai M Britz, Gavin W Constable, Mark Fonarow, Gregg C Schwamm, Lee Peterson, Eric D Shah, Bimal R |
author_facet | Lin, Cheryl B Cox, Margueritte Olson, DaiWai M Britz, Gavin W Constable, Mark Fonarow, Gregg C Schwamm, Lee Peterson, Eric D Shah, Bimal R |
author_sort | Lin, Cheryl B |
collection | PubMed |
description | BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is whether hospitals accurately perceive their rate of tPA “door-to-needle” (DTN) time within 60 minutes and how DTN rates compare across different hospitals. METHODS AND RESULTS: DTN performance was defined by the percentage of treated patients who received tPA within 60 minutes of arrival. Telephone surveys were obtained from staff at 141 Get With The Guidelines hospitals, representing top, middle, and lowDTN performance. Less than one-third (29.1%) of staff accurately identified their DTN performance. Among middle- and low-performing hospitals (n=92), 56 sites (60.9%) overestimated their performance; 42% of middle performers and 85% of low performers overestimated their performance. Sites that overestimated tended to have lower annual volumes of tPA administration (median 8.4 patients [25th to 75th percentile 5.9 to 11.8] versus 10.2 patients [25th to 75th percentile 8.2 to 17.3], P=0.047), smaller percentages of eligible patients receiving tPA (84.7% versus 89.8%, P=0.008), and smaller percentages of DTN ≤60 minutes among treated patients (10.6% versus 16.6%, P=0.002). CONCLUSIONS: Hospitals often overestimate their ability to deliver timely tPA to treated patients. Our findings indicate the need to routinely provide comparative provider performance rates as a key step to improving the quality of acute stroke care. |
format | Online Article Text |
id | pubmed-4608060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46080602015-10-16 Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke Lin, Cheryl B Cox, Margueritte Olson, DaiWai M Britz, Gavin W Constable, Mark Fonarow, Gregg C Schwamm, Lee Peterson, Eric D Shah, Bimal R J Am Heart Assoc Original Research BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is whether hospitals accurately perceive their rate of tPA “door-to-needle” (DTN) time within 60 minutes and how DTN rates compare across different hospitals. METHODS AND RESULTS: DTN performance was defined by the percentage of treated patients who received tPA within 60 minutes of arrival. Telephone surveys were obtained from staff at 141 Get With The Guidelines hospitals, representing top, middle, and lowDTN performance. Less than one-third (29.1%) of staff accurately identified their DTN performance. Among middle- and low-performing hospitals (n=92), 56 sites (60.9%) overestimated their performance; 42% of middle performers and 85% of low performers overestimated their performance. Sites that overestimated tended to have lower annual volumes of tPA administration (median 8.4 patients [25th to 75th percentile 5.9 to 11.8] versus 10.2 patients [25th to 75th percentile 8.2 to 17.3], P=0.047), smaller percentages of eligible patients receiving tPA (84.7% versus 89.8%, P=0.008), and smaller percentages of DTN ≤60 minutes among treated patients (10.6% versus 16.6%, P=0.002). CONCLUSIONS: Hospitals often overestimate their ability to deliver timely tPA to treated patients. Our findings indicate the need to routinely provide comparative provider performance rates as a key step to improving the quality of acute stroke care. John Wiley & Sons, Ltd 2015-07-23 /pmc/articles/PMC4608060/ /pubmed/26201547 http://dx.doi.org/10.1161/JAHA.114.001298 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Lin, Cheryl B Cox, Margueritte Olson, DaiWai M Britz, Gavin W Constable, Mark Fonarow, Gregg C Schwamm, Lee Peterson, Eric D Shah, Bimal R Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke |
title | Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke |
title_full | Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke |
title_fullStr | Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke |
title_full_unstemmed | Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke |
title_short | Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke |
title_sort | perception versus actual performance in timely tissue plasminogen activation administration in the management of acute ischemic stroke |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608060/ https://www.ncbi.nlm.nih.gov/pubmed/26201547 http://dx.doi.org/10.1161/JAHA.114.001298 |
work_keys_str_mv | AT lincherylb perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT coxmargueritte perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT olsondaiwaim perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT britzgavinw perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT constablemark perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT fonarowgreggc perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT schwammlee perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT petersonericd perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke AT shahbimalr perceptionversusactualperformanceintimelytissueplasminogenactivationadministrationinthemanagementofacuteischemicstroke |